A member of the CPW-WPC protein family is expressed in and localized to the surface of developing ookinetes
© Kangwanrangsan et al.; licensee BioMed Central Ltd. 2013
Received: 21 September 2012
Accepted: 8 April 2013
Published: 15 April 2013
Despite the development of malaria control programs, billions of people are still at risk for this infectious disease. Recently, the idea of the transmission-blocking vaccine, which works by interrupting the infection of mosquitoes by parasites, has gained attention as a promising strategy for malaria control and eradication. To date, a limited number of surface proteins have been identified in mosquito-stage parasites and investigated as potential targets for transmission-blocking vaccines. Therefore, for the development of effective transmission-blocking strategies in epidemic areas, it is necessary to identify novel zygote/ookinete surface proteins as candidate antigens.
Since the expression of many zygote/ookinete proteins is regulated post-transcriptionally, proteins that are regulated by well-known translational mediators were focused. Through in silico screening, CPW-WPC family proteins were selected as potential zygote/ookinete surface proteins. All experiments were performed in the rodent malaria parasite, Plasmodium yoelii XNL. mRNA and protein expression profiles were examined by RT-PCR and western blotting, respectively, over the course of the life cycle of the malaria parasite. Protein function was also investigated by the generation of gene-disrupted transgenic parasites.
The CPW-WPC protein family, named after the unique WxC repeat domains, is highly conserved among Plasmodium species. It is revealed that CPW-WPC mRNA transcripts are transcribed in gametocytes, while CPW-WPC proteins are expressed in zygote/ookinete-stage parasites. Localization analysis reveals that one of the CPW-WPC family members, designated as PyCPW-WPC-1, is a novel zygote/ookinete stage-specific surface protein. Targeted disruption of the pycpw-wpc-1 gene caused no obvious defects during ookinete and oocyst formation, suggesting that PyCPW-WPC-1 is not essential for mosquito-stage parasite development.
It is demonstrated that PyCPW-WPC-1 can be classified as a novel, post-transcriptionally regulated zygote/ookinete surface protein. Additional studies are required to determine whether all CPW-WPC family members are also present on the ookinete surface and share similar biological roles during mosquito-stage parasite development. Further investigations of CPW-WPC family proteins may facilitate understanding of parasite biology in the mosquito stage and development of transmission-blocking vaccines.
KeywordsMalaria Transmission-blocking vaccine Mosquito Post-transcriptional regulation CPW-WPC protein
Malaria is a serious tropical disease caused by infection with Plasmodium parasites that are transmitted via Anopheles mosquitoes. While intense efforts in malaria control have affected a gradual decrease in the global number of malaria cases and deaths every year since 2005, an estimated 3.3 billion people were still at risk of malaria infection in 2010 . The World Health Organization (WHO) has recommended two major strategies currently in use for malaria control: the prevention of mosquito bites using long-lasting insecticide-treated mosquito nets (LLINs) and indoor residual spraying (IRS) and the management of malaria cases with artemisinin-based combination therapy (ACT) and rapid diagnosis [1, 2]. Despite extensive attempts to develop vaccine strategies to inhibit parasite proliferation in human hosts (pre-erythrocytic- and erythrocytic-stage vaccines), no vaccines have been developed for clinical use to date . In contrast, transmission-blocking vaccine (TBV) strategies, which aim to interrupt parasite development in the mosquito vector, have recently been revealed as effective methods for the elimination and eradication of malaria . Moreover, it has been suggested that TBV, in combination with blood-stage vaccines or anti-malarial drugs, could prevent the emergence of vaccine- or drug-resistant parasites [5, 6].
Malaria transmission to mosquito vectors is initiated when male and female gametocytes are acquired during blood sucking. Gametocytes undergo development into gametes in the midgut and then mate to form zygotes. Later, they mature into ookinetes, the invasive form of the parasite that can penetrate the midgut epithelium. The principle idea of TBV is to interrupt parasite mating, development, or invasion inside the mosquito midgut using antibodies produced in human hosts and acquired, together with gametocytes, by mosquitoes during the blood meal. Therefore, TBV has the potential to break the life cycle of parasites in mosquito vectors .
Screening for TBV target antigens typically focuses on proteins expressed on the surface of parasites during the sexual stages (gametocytes and gametes) and/or mosquito-stages (zygotes and ookinetes) [8, 9]. Several surface proteins have been identified as candidates for TBV antigens, including P25, P28, P230, P48/45, and PCCps/LAPs (LCCL/lectin adhesive-like protein) [10, 11]. Studies using membrane-feeding assays have demonstrated that anti-P25 and anti-P28 antibodies inhibit parasite invasion in the mosquito midgut . However, stepwise clinical examinations, together with further screening for candidate antigens, are necessary for the development of TBV strategies.
To screen candidate antigens for TBV, two criteria were set: 1) proteins should be expressed exclusively from gametes to ookinetes, and 2) proteins should be localized to the surface of parasites. Progress in genetic manipulation has revealed a number of proteins that are important for parasite development in mosquitoes, such as calcium-dependent protein kinase 4 (CDPK4) in exflagellation , P48/45 and hapless 2/generative cell-specific 1 (HAP2/GCS1) in gamete fertilization [14–16], and several proteins in ookinete motility and invasion (reviewed in ). Most of these molecules are regulated post-transcriptionally by messenger ribonucleoproteins, development of zygote inhibited (DOZI), and homolog of worm CAR-I and fly Trailer Hitch (CITH) [18, 19].
In the current study, a novel malaria protein family, CPW-WPC, which is expressed on the surface of developing ookinetes, is identified by focusing on predicted secretory and post-transcriptionally regulated proteins. These findings suggest that CPW-WPC family proteins may be potential candidate antigens for transmission-blocking strategies.
Experimental infection of mice by parasites
All the animal experiments were conducted in accordance with the guide for animal experimentation at Ehime University, Graduate School of Medicine. Eight-week-old female BALB/c mice (CLEA Japan Inc., Tokyo, Japan), pretreated with 0.2 mL of 0.6 mg/mL phenylhydrazine, were injected intraperitoneally with P. yoelii 17XNL parasites. To obtain only gametocytes, asexual-stage parasites were eliminated by intraperitoneal injection of 0.25 mL sulfadiazine (2 mg/mL) 24 h before blood collection.
Collection of parasites
For blood-stage parasites, infected blood (at 10–20% parasitaemia) was mixed with 5 volumes of ice-cold incomplete medium (ICM; RPMI1640 medium, pH 7.4, Invitrogen) and then passed through a sterile CF11 filter (Whatman, England) to remove white blood cells. Cells were pelleted at 1,200 × g for 5 min and washed with ice-cold ICM before antigen preparation. For in vitro ookinete culture, infected blood was immediately mixed with 5 volumes of SA buffer (10 mM Tris, 150 mM NaCl, 10 mM glucose, pH 7.3, warmed to 37°C) to prevent gamete exflagellation and then passed through a sterile CF11 filter. After washing with ICM (warmed to 37°C), the parasites were resuspended with 20 volumes of ookinete culture medium (OCM; 24°C), composed of RPMI1640 medium containing 20% heat-inactivated fetal calf serum, 0.367 mM hypoxanthine, 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 5 U/mL heparin (pH 8.3). The parasites were then transferred into culture flasks and incubated at 24°C. At 0, 1, 4, 16, and 24 h after incubation, equal volumes of cultured ookinetes were collected and washed with ice-cold ICM before antigen preparation.
Preparation of parasite antigens
Parasite samples were purified by density gradient centrifugation using Percoll (GE Healthcare, USA). Briefly, parasite pellets were gently mixed with 4 volumes of ICM, layered onto 50% Percoll, and centrifuged at 410 × g for 20 min at room temperature. Purified parasites were collected from the interface, washed twice, and resuspended in 2 volumes of ICM. The purity was checked microscopically using Giemsa-stained blood smears, and the parasite number was determined by counting under a haemocytometer before spotting onto glass slides for the immunofluorescent assay. To prepare the antigens for western blotting, the purified parasites were treated for 10 min at 4°C with 0.15% saponin in ICM containing protease inhibitors (Roche, Germany). The samples were washed twice with 0.1 M phosphate-buffered saline (PBS) containing protease inhibitors (PBS-PI) and were stored as pellets at -80°C until use. For the collection of sporozoites, the salivary glands were dissected from infected mosquitoes at day 15 post-feeding and then ground in ice-cold ICM to release sporozoites.
The genomic sequences used in this study were obtained from PlasmoDB, the Plasmodium Genomics Resource . The putative signal peptide and CPW-WPC domains were also investigated. Multiple sequence alignments of CPW-WPC family members were performed with ClustalW (MegAlign; Lasergene®).
RT-PCR of pycpw-wpc-1 and CPW-WPC family member transcripts
Total RNA was isolated from in vitro cultured ookinetes using the RNeasy Micro Kit (Qiagen). To obtain cDNA, total RNA was subjected to reverse transcription and subsequent PCR using the PrimeScript reagent kit (TAKARA, Japan). The transcriptional profiles of pycpw-wpc-1, py00599, py03515, py04297, and pyhsp70 were determined by conventional PCR at 28 cycles using gene-specific primers (see Additional file 1). cDNA concentrations were normalized across samples to pyhsp70 expression. PCR products were analysed using ImageQuant LAS 4000 (GE Healthcare), and band intensities were measured using Adobe Photoshop (Adobe System Inc., USA).
Expression of recombinant PyCPW-WPC-1 (rPyCPW-WPC-1)
The target gene was amplified from P. yoelii 17XNL zygote-enriched cDNA by PCR using the Phusion High-Fidelity DNA Polymerase (FINNZYMES, Finland). A gene-specific primer set (forward, 5′-CTCGAG AAAACGTTTGTCTTTTCTGGAGACG-3′ and –reverse, 5′-GGATCC TTAAATAATTGATCCAGTTATTGAATCC-3′) was designed to amplify the target sequence (1,539 base pairs), excluding the N-terminal signal sequence. The PCR fragment was cloned into the pEU-E01-GST-TEV-MCS-N2 vector (CellFree Sciences Co. Ltd., Matsuyama, Japan), as previously described . Plasmids were then utilized for protein production in a wheat germ cell-free protein expression system using the bilayer translation reaction method [22, 23]. GST-fused rPyCPW-WPC-1 was bound to a glutathione Sepharose 4B column, followed by cleavage with a tobacco etch virus protease to elute the rPyCPW-WPC-1 protein from the column. The yield was analyzed by Bradford’s assay and conventional SDS-PAGE with Coomassie brilliant blue staining.
Production of anti-PyCPW-WPC-1 antibodies
Eight-week-old female BALB/c mice were immunized by intraperitoneal injection of rPyCPW-WPC-1 in Freund’s adjuvant (Wako, Japan) 3 times (30 μg in 0.2 mL each) at 3-week-intervals. Immune sera were obtained two weeks after the last immunization. The reactivity and specificity of anti-rPyCPW-WPC-1 antisera were determined by ELISA and western blotting.
SDS-PAGE and western blotting
Parasite pellets were extracted with 1% Triton X-100 in PBS-PI. To solubilize the parasite antigens, the mixture was incubated on ice for 1 h. After centrifugation, the supernatant was recovered into a new microcentrifuge tube and mixed with loading buffer containing 2-β-mercaptoethanol at 4% of the final volume. Antigens were then loaded onto 12.5% polyacrylamide gels (ATTO Bioscience & Biotechnology, Japan) at 0.5–1 × 105 parasites/lane and run in an electrophoresis buffer under a constant current. The separated proteins were then transferred onto PVDF membranes (Millipore) using a semidry transfer system. After transfer, membranes were incubated with 5% skim milk in PBS containing 0.1% Tween20 (PBST) at room temperature for 2 h, followed by incubation with mouse anti-PyCPW-WPC-1 antiserum (dilution, 1:100) for 1 h. After washing with PBST, the membranes were then incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (dilution, 1:20,000; Invitrogen) for 30 min. Unbound antibodies were washed out with PBST, and membranes were incubated with a chemiluminescent-HRP substrate (Immobilon Western, Millipore), wrapped in a cassette, and exposed to X-ray film (Fujifilm Corporation, Tokyo, Japan). Exposed films were developed using a CEPROS SV machine (Fujifilm Corporation).
Indirect immunofluorescent assay (IFA)
Antigen slides were fixed with ice-cold acetone for 5 min. Nonspecific binding was then blocked with 5% skim milk in PBS at 37°C for 30 min before incubation with antibodies (mouse anti-PyCPW-WPC-1 at a dilution of 1:100 and rabbit anti-Pys25 at a dilution of 1:10,000) at 37°C for 1 h. The slides were then washed in PBS for 5 min and subsequently incubated with Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor 546 goat anti-rabbit IgG (Invitrogen) diluted in PBS containing 1 μg/mL 4′6-diamidino-2-phenylindole (DAPI) at 37°C for 30 min. After washing out the unbound antibodies, the coverslips were mounted with Prolong Gold antifade reagent (Invitrogen), and the slides were observed under a confocal microscope (LSM710; Carl Zeiss, Germany). The resulting images were analysed using the Zen software (Carl Zeiss, Germany).
Targeted gene disruption of pycpw-wpc-1
Pycpw-wpc-1 was disrupted by double-crossover homologous recombination in P. yoelii 17XNL. Two basic plasmids, pPbDT3UB12 and pHDEF1-mh-R12, were used for the construction of transfection plasmids, as previously described . In brief, target sequences were amplified by PCR using KOD Plus DNA polymerase (Toyobo, Japan) with primer sets targeting the 809-base pair region upstream (-forward, 5′-CTCGAG TATGCATAATTGTGAATAGTTATTGG-3′ and –reverse, 5′-GGATCC GACCCCTATAATAATAAAAGGTCTGTC-3′) and 755-base pair region downstream (-forward, 5′-AGATCT ACCAGATGATTATAATGGACCTTGTCC-3′ and –reverse, 5′-CTCGAG CGGATGTATTGAGAAGCTTTACATGTG-3′) of pycpw-wpc-1. PCR products were subsequently digested and inserted into pPbDT3UB12. Using Gateway Technology (Invitrogen), the modified pPbDT3UB12 plasmid was then subjected to a BP recombination reaction with the donor vector pDONR221 to give the entry plasmid. This entry plasmid was then subjected to an LR recombination reaction with pHDEF-1-mh-R12 to yield the final construct, which was linearized with Xho I before use. Enriched schizonts were transfected with 20 μg of linearized construct by electroporation using Nucleofector (Lonza) with a human T cell solution and the U-33 program. Transfected parasites were delivered into 8-week-old BALB/c female mice by intravenous injection. Twenty-four hours later, the mice were treated with pyrimethamine (70 μg/mL) via their drinking water. Infected blood was collected to examine the integration of the disruption cassette by PCR using the KOD FX DNA polymerase with a unique set of primers. Successfully transfected parasites were cloned using the limiting dilution technique, and cloned parasites were cultured for ookinetes. The expression of PyCPW-WPC-1 was measured by western blotting and IFA using mouse anti-PyCPW-WPC-1 antibodies.
Mosquito feeding assay
More than 50 female Anopheles stephensi mosquitoes were allowed to fed on mice infected with wild-type- or gene-disrupted parasites, and only mosquitoes that showed complete engulfment of the blood were selected for an additional two weeks of incubation at 24°C. For infectivity analysis, mosquito midguts were dissected on day 10 post-feeding, and oocyst numbers were counted under a microscope. To examine sporozoite-formation ability, sporozoites were collected from midguts on day 15 post-feeding and counted.
Identification of Plasmodium CPW-WPC family members
Members of CPW-WPC domain protein family
PBANKA (PY ortholog)
coding seq. (bp)
amino acid (residues)
DOZI KO vs. WT (confidence)
Data from PlasmoDB (http://plasmodb.org/plasmo)
Here, one of the CPW-WPC family proteins (PBANKA_135250) was selected for further investigation in another rodent malaria parasite (P. yoelii 17XNL). Since the nucleotide sequence of the orthologous gene in P. yoelii (designated as PyCPW-WPC-1) has not yet been fully identified on PlasmoDB, PCR analyses of both genomic DNA and cDNA were performed to determine the primary sequence and its exon-intron structure. Multiple amino acid sequence alignment of the PyCPW-WPC-1 protein showed 93–94% and 50–55% identity among the orthologs related to rodent (PBANKA_135250 and PCHAS_135710) and human malaria parasites (PF3D7_1338800, PVX_082875, and PKH_121500), respectively. Furthermore, all eight CPW-WPC family members are described on PlasmoDB as DOZI-dependent post-transcriptionally regulated proteins. Taken together, these data suggest that CPW-WPC domain proteins tend to be expressed in zygotes and/or ookinetes.
Expression of pycpw-wpc-1 mRNAs before ookinete formation
PyCPW-WPC-1 is a zygote/ookinete stage-specific protein
To obtain specific antibodies targeting PyCPW-WPC-1, full-length recombinant PyCPW-WPC-1 without a signal sequence (rPyCPW-WPC-1) was synthesized using a wheat germ cell-free protein expression system. After purification, rPyCPW-WPC-1 was obtained as the major band with a molecular weight of about 60 kDa (Figure 2C), and this purified product was then used for immunization in mice. Antisera were collected from immunized mice and used for western blotting to study the expression of the target protein during the malaria life cycle, including schizont-enriched blood-stage parasites, ookinetes, and sporozoites collected from mosquito salivary glands. The results demonstrated that PyCPW-WPC-1 was produced exclusively in ookinetes (Figure 2D). Moreover, western blotting analysis using the same in vitro cultured ookinete samples as used for transcriptional analysis (see Figure 2A) showed that PyCPW-WPC-1 expression was very low in gametes (0 h), despite the presence of pycpw-wpc-1 transcripts. The expression of PyCPW-WPC-1 protein became prominent at 1 and 4 h of ookinete culture and decreased gradually until 24 h of ookinete maturation (Figure 2E). From morphological observations using Giemsa’s stain, it is concluded that translation of PyCPW-WPC-1 starts during zygote and early ookinete development. Together with our transcriptional data, these results demonstrate that the expression of PyCPW-WPC-1 is regulated post-transcriptionally, as predicted by microarray analyses of pbdozi- disrupted parasites .
Localization of PyCPW-WPC-1 to the zygote/ookinete surface
PyCPW-WPC-1 is not essential for ookinete formation
After the discovery that the zygote/ookinete surface proteins, P25 and P28, could be good candidate antigens for TBVs, considerable effort has been made to identify additional surface proteins; however, these attempts have not been successful. This study demonstrates that a member of the CPW-WPC protein family (PyCPW-WPC-1) is expressed during zygote and ookinete development in mosquitoes and is localized to the surface of developing ookinetes in P. yoelii. Database analyses using P. berghei demonstrate that the CPW-WPC family contains eight proteins, as shown in Table 1. Interestingly, studies have shown that the transcription of all CPW-WPC members is reduced in pbdozi mutants , indicating that all family members are expressed during the sexual stage under DOZI-dependent post-translational control. This characteristic can also be found in several hundred other proteins expressed in ookinetes, as demonstrated by studies on regulatory molecules, such as DOZI, CITH, HMGB2, and MISFIT [18, 19, 26, 27].
Similar to the structure of P25 and P28, CPW-WPC proteins also contain conserved cysteine domains (Figure 1A). Despite the absence of transmembrane or glycosylphosphatidylinositol (GPI) anchor domains, two members of the CPW-WPC protein family were found to be localized to the ookinete surface (Figure 3). Moreover, by algorithmic analysis using MAAP , CPW-WPC proteins appeared in the predicted adhesin group, suggesting that they may be involved in host parasite interactions during ookinete development and/or migration in the mosquito midgut. It was also shown here that targeted pycpw-wpc-1 gene disruption had no significant effect on ookinete or sporozoite formation. Since at least one other CPW-WPC protein (Py03515) showed a similar ookinete surface localization pattern (Additional file 2), it is possible that other family members could compensate for PyCPW-WPC-1 function. Therefore, it would be interesting to determine whether all CPW-WPC family members are expressed at the same time on the ookinete surface or whether there is exclusive expression of these proteins, as is seen for var genes, a family of Plasmodium falciparum virulence genes . Thus, for further functional analysis of this protein family, double gene disruption should be attempted.
Due to their ookinete surface localization pattern, CPW-WPC family proteins may be potential candidates for transmission-blocking antigens, regardless of whether CPW-WPC-1 is dispensable in parasite transmission to mosquitoes. Previous reports have demonstrated that specific antibodies against P25 and P28 inhibited parasite transmission in mosquito midguts, although single disruption of each gene showed no clear defects during mosquito-stage development [12, 30]. Moreover, CPW-WPC proteins are conserved among Plasmodium species, including P. falciparum and Plasmodium vivax, and CPW-WPC family proteins are less polymorphic than known blood-stage vaccine targets, such as apical membrane antigen 1 (AMA1) and merozoite surface protein 1 (MSP1). These characteristics are clinically important for vaccine development; therefore, further studies including transmission-blocking assays using specific antibodies against CPW-WPC family proteins should be required.
The current study describes PyCPW-WPC-1, a novel post-transcriptionally regulated ookinete surface protein. This protein contains CPW-WPC domains, composed of conserved cysteine residues. In silico analysis shows that there are eight members of the CPW-WPC protein family, all of which are regulated by DOZI, a post-transcriptional regulatory factor that functions during parasite development in mosquitoes. By targeted gene disruption, it is demonstrated that PyCPW-WPC-1 is dispensable during ookinete development and invasion of midgut epithelium, which may suggest the redundancy of CPW-WPC family proteins. The identification of this novel ookinete surface protein family could be useful for understanding biology of mosquito-stage parasite development and for detecting possible candidates for transmission-blocking vaccine targets.
Development of zygote inhibited
Homolog of worm CAR-I and fly Trailer Hitch
Ookinete culture medium
Polymerase chain reaction
Glutathione S transferase
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
Indirect immunofluorescent assay
This study was supported by JSPS KAKENHI (grant number 21406010) to MT and JSPS KAKENHI (grant number 22406007) to TI.
- World Health Organization: World Malaria Report. 2011, Geneva, Switzerland: World Health Organization
- Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systemic analysis. Lancet. 2012, 379: 413-431. 10.1016/S0140-6736(12)60034-8.View ArticlePubMed
- Schwartz L, Brown GV, Genton B, Moorthy VS: A review of malaria vaccine clinical projects based on WHO rainbow table. Malar J. 2012, 11: 11-10.1186/1475-2875-11-11.PubMed CentralView ArticlePubMed
- Breman JG, Brandling-Bennett AD: The challenge of malaria eradication in the twenty-first century: Research linked to operations is the key. Vaccine. 2011, 29S: D97-D103.View Article
- Greenwood BM, Fidock DA, Kyle DE, Kappe SHI, Alonso PL, Collins FH, Duffy PE: Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008, 118: 1266-1276. 10.1172/JCI33996.PubMed CentralView ArticlePubMed
- Genton B: Malaria vaccines: a toy for travellers or a tool for eradication?. Expert Rev Vaccine. 2008, 7: 597-611. 10.1586/147605126.96.36.1997.View Article
- Carter R: Transmission blocking malaria vaccines. Vaccine. 2001, 19: 2309-2314. 10.1016/S0264-410X(00)00521-1.View ArticlePubMed
- Ghosh A, Edwards MJ, Jacobs-Lorena : The journey of the malaria parasite in the mosquito: Hope for the new century. Parasitol Today. 2000, 16: 196-2001. 10.1016/S0169-4758(99)01626-9.View ArticlePubMed
- Carter R, Kumar N, Quakyi I, Good M, Mendis K, Graves P, Miller L: Immunity to sexual stage of malaria parasites. Prog Allergy. 1988, 41: 193-214.PubMed
- Targett GA, Greenwood BM: Malaria vaccines and their potential role in elimination of malaria. Malar J. 2008, 7 (Suppl I): S10-PubMed CentralView ArticlePubMed
- Scholz SM, Simon N, Lavazec C, Dude MA, Templeton TJ, Pradel G: Pf CCp proteins of Plasmodium falciparum: gametocyte-specific expression and role in complement-mediated inhibition of exflagellation. Int J Parasitol. 2008, 38: 327-340. 10.1016/j.ijpara.2007.08.009.View ArticlePubMed
- Tsuboi T, Cao Y, Hitsumoto Y, Yanagi T, Kanbara H, Torii M: Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. Infect Immun. 1997, 65: 2260-2264.PubMed CentralPubMed
- Billker O, Dechamps S, Tewari R, Wenig G, Franke-Fayard B, Brinkmann V: Calcium and a calcium-dependent protein kinase regulate gamete formation and mosquito transmission in malaria parasite. Cell. 2004, 117: 503-514. 10.1016/S0092-8674(04)00449-0.View ArticlePubMed
- van Dijk MR, Janse CJ, Thompson J, Waters AP, Braks JA, Dodemont HJ, Stunnenberg HG, van Gemert G, Sauerwein RW, Eling W: A central role for P48/45 in malaria parasite male gamete fertility. Cell. 2001, 104: 153-164. 10.1016/S0092-8674(01)00199-4.View ArticlePubMed
- Liu Y, Tewari R, Ning J, Blagborough AM, Garbom S, Pei J, Grishin NV, Steele RE, Sinden RE, Snell WJ, Billker O: The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes. Genes Dev. 2008, 22: 1051-1068. 10.1101/gad.1656508.PubMed CentralView ArticlePubMed
- Hirai M, Arai M, Mori T, Miyagishima S, Kawai S, Kita K, Kuroiwa T, Terenius O, Matsuoka H: Male fertility of malaria parasites is determined by GCS1, a plant-type reproduction factor. Curr Biol. 2008, 18: 607-613. 10.1016/j.cub.2008.03.045.View ArticlePubMed
- Angrisano F, Tan Y, Sturm A, Baum J: Malaria parasite colonisation of the mosquito midgut – Placing the Plasmodium ookinete centre stage. Int J Parasitol. 2012, 42: 519-527. 10.1016/j.ijpara.2012.02.004.View ArticlePubMed
- Mair GR, Braks JAM, Garver LS, Wiegant JCAG, Hall N, Dirks RW, Khan SM, Dimopoulos G, Janse CJ, Waters AP: Regulation of sexual development of Plasmodium by translational repression. Science. 2006, 313: 667-669. 10.1126/science.1125129.PubMed CentralView ArticlePubMed
- Mair GR, Lasonder E, Garver LS, Franke-Fayard BMD, Carret CK, Wiegant JCAG, Dirks RW, Dimopoulos G, Janse CJ, Waters AP: Universal features of post-transcriptional gene regulation are critical for Plasmodium zygote development. PLoS Pathog. 2010, 6: 1-12.View Article
- Plasmodium Genomics Resource:http://plasmodb.org/plasmo,
- Tsuboi T, Takeo S, Iriko H, Jin L, Tsuchimochi M, Matsuda S, Han E, Otsuki H, Kaneko O, Sattabongkot J, Udomsangpetch R, Sawasaki T, Torii M, Endo Y: Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun. 2008, 76: 1702-1708. 10.1128/IAI.01539-07.PubMed CentralView ArticlePubMed
- Sawasaki T, Ogasawara T, Morishita R, Endo Y: A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci USA. 2002, 99: 14652-14657. 10.1073/pnas.232580399.PubMed CentralView ArticlePubMed
- Takai K, Sawasaki T, Endo Y: Practical cell-free protein synthesis system using purified wheat embryos. Nat Protoc. 2010, 5: 227-238. 10.1038/nprot.2009.207.View ArticlePubMed
- Otsuki H, Kaneko O, Thongkukiatkul A, Tachibana M, Iriko H, Takeo S, Tsuboi T, Torii M: Single amino acid substitution in Plasmodium yoelii erythrocyte ligand determines its localization and controls parasite virulence. Proc Natl Acad Sci USA. 2009, 106: 7167-7172. 10.1073/pnas.0811313106.PubMed CentralView ArticlePubMed
- Aurrecoechea C, Brestelli J, Brunk BP, Carlton JM, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, Grant G, Harb OS, Heiges M, Innamorato F, Iodice J, Kissinger JC, Kraemer E, Li W, Miller JA, Morrison HG, Nayak V, Pennington C, Pinney DF, Roos DS, Ross C, Stoeckert CJ, Sullivan S, Treatman C, Wang H: PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009, 37: D539-D543. 10.1093/nar/gkn814.PubMed CentralView ArticlePubMed
- Gissot M, Ting L, Daly TM, Bergman LW, Sinnis P, Kim K: High mobility group protein HMGB2 is a critical regulator of Plasmodium oocyst development. J Biol Chem. 2008, 283: 17030-17038. 10.1074/jbc.M801637200.PubMed CentralView ArticlePubMed
- Bushell ESC, Ecker A, Schlegelmilch T, Goulding D, Dougan G, Sinden RE, Christophides GK, Kafatos FC, Vlachou D: Paternal effect of the nuclear formin-like protein MISFIT on Plasmodium development in the mosquito vector. PLoS Pathog. 2009, 5: e1000539-10.1371/journal.ppat.1000539.PubMed CentralView ArticlePubMed
- Ansari FA, Kumar N, Subramanyam MB, Gnanamani M, Ramachandran S: MAAP: Malaria adhesins and adhesin-like proteins predictor. Proteins. 2008, 70: 659-666.View ArticlePubMed
- Kim K: Malaria var gene expression: keeping up with the neighbors. Cell Host Microbe. 2012, 11: 1-2. 10.1016/j.chom.2012.01.002.PubMed CentralView ArticlePubMed
- Tomas AM, Margos G, Dimopoulos G, van Lin LH, Koning-Ward TF, Sinha R, Lupetti P, Beetsma AL, Rodriguez MC, Karras M, Hager A, Mendoza J, Butcher GA, Kafatos F, Janse CJ, Waters AP, Sinden RE: P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. EMBO J. 2001, 20: 3975-3983. 10.1093/emboj/20.15.3975.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.